Your browser doesn't support javascript.
loading
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.
Mikami, Masamitsu; Masuda, Tatsuya; Kanatani, Takuya; Noura, Mina; Umeda, Katsutsugu; Hiramatsu, Hidefumi; Kubota, Hirohito; Daifu, Tomoo; Iwai, Atsushi; Hattori, Etsuko Yamamoto; Furuichi, Kana; Takasaki, Saho; Tanaka, Sunao; Matsui, Yasuzumi; Matsuo, Hidemasa; Hirata, Masahiro; Kataoka, Tatsuki R; Nakahata, Tatsutoshi; Kuwahara, Yasumichi; Iehara, Tomoko; Hosoi, Hajime; Imai, Yoichi; Takita, Junko; Sugiyama, Hiroshi; Adachi, Souichi; Kamikubo, Yasuhiko.
Afiliação
  • Mikami M; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Masuda T; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Kanatani T; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Noura M; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Umeda K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Hiramatsu H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Kubota H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Daifu T; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Iwai A; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Hattori EY; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Furuichi K; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Takasaki S; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Tanaka S; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Matsui Y; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Matsuo H; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Hirata M; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto 606-8507, Japan.
  • Kataoka TR; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto 606-8507, Japan.
  • Nakahata T; Drug Discovery Technology Development Office, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
  • Kuwahara Y; Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
  • Iehara T; Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
  • Hosoi H; Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
  • Imai Y; Department of Hematology/Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Takita J; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Sugiyama H; Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto 606-8303, Japan.
  • Adachi S; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
  • Kamikubo Y; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
Mol Cells ; 45(12): 886-895, 2022 Dec 31.
Article em En | MEDLINE | ID: mdl-36572559
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumor Rabdoide / Subunidade alfa 2 de Fator de Ligação ao Core / Survivina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumor Rabdoide / Subunidade alfa 2 de Fator de Ligação ao Core / Survivina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article